Tissue adhesives for meniscus tear repair: an overview of current advances and prospects for future clinical solutions
- 2.1k Downloads
Menisci are crucial structures in the knee joint as they play important functions in load transfer, maintaining joint stability and in homeostasis of articular cartilage. Unfortunately, ones of the most frequently occurring knee injuries are meniscal tears. Particularly tears in the avascular zone of the meniscus usually do not heal spontaneously and lead to pain, swelling and locking of the knee joint. Eventually, after a (partial) meniscectomy, they will lead to osteoarthritis. Current treatment modalities to repair tears and by that restore the integrity of the native meniscus still carry their drawbacks and a new robust solution is desired. A strong tissue adhesive could provide such a solution and could potentially improve on sutures, which are the current gold standard. Moreover, a glue could serve as a carrier for biological compounds known to enhance tissue healing. Only few tissue adhesives, e.g., Dermabond® and fibrin glue, are already successfully used in clinical practice for other applications, but are not considered suitable for gluing meniscus tissue due to their sub-optimal mechanical properties or toxicity. There is a growing interest and research field focusing on the development of novel polymer-based tissue adhesives, but up to now, there is no material specially designed for the repair of meniscal tears. In this review, we discuss the current clinical gold standard treatment of meniscal tears and present an overview of new developments in this field. Moreover, we discuss the properties of different tissue adhesives for their potential use in meniscal tear repair. Finally, we formulate recommendations regarding the design criteria of material properties and adhesive strength for clinically applicable glues for meniscal tears.
KeywordsChitosan Articular Cartilage Fibrin Glue Lateral Meniscus Cyanoacrylate
Menisci are crescent shaped discs of fibrocartilage with a triangular cross-section, present in duplicate in each knee joint. The menisci have been recognized as crucial structures in maintaining knee joint stability and articular cartilage homeostasis [1, 2, 3]. During normal functioning, they are exposed to shear, tension and compression forces and serve a variety of (bio)mechanical functions, such as load bearing, constituting contact area, guiding rotation and stabilizing translation [4, 5, 6, 7]. They also play a role in lubrication and nutrition of the underlying articular cartilage surfaces and by that might help to prevent the development of osteoarthritis .
The most commonly occurring injuries of the knee joint are meniscus tears. They originate either from acute injuries of the knee joint (e.g. sport, trauma) or are caused by degenerative changes (mostly in case of elderly patients) associated with early osteoarthritis . Irrespective to their origin, they might cause pain, swelling and locking of the joint, and they may ultimately lead to osteoarthritis . Therefore, it is of utmost importance to provide an effective treatment modality and to prevent this negative scenario.
In the past, it was believed that menisci could be removed without any immediate or long-term consequences for the function of the knee joint and consequently a (partial) meniscectomy was performed as a gold standard treatment. In fact, short-term results were very satisfactory. It resulted in instant pain relief and restoration of knee function, but as osteoarthritis develops very slowly, it took decades to find out that even a partial meniscectomy inevitably leads to joint degeneration [10, 11]. In 1975 Krause et al. showed that menisci have a function in load-transmission and stress absorption in the knee and that peak stresses acting on articular cartilage increase after meniscectomy . Removal of only 15–34 % of the meniscus, a partial meniscectomy, will produce a 350 % increase in contact stress and lead to development of degenerative changes and eventually osteoarthritis in a majority of the patients . Ever since, the preferred strategies aim at restoration of the integrity of the meniscus rather than at its removal by (partial) meniscectomy . These treatment methods can only be effective if the torn parts of the tissue are kept in close proximity to each other enabling a healing process to take place. Many devices have been developed and tested in clinical practice for this purpose, such as sutures, stingers, staples, arrows and darts [14, 15]. However, the success rate of these devices highly depend on the location of the meniscal lesion . They are mainly effective in treating lesions located in the peripheral vascularized region of the meniscus [17, 18]. Moreover, the techniques are challenging, surgical procedure is time-consuming and devices are expensive. Therefore, it would be ideal to find an alternative treatment method, which should be easier and faster to perform, and would allow a more universal successful treatment of tears, also those located in the avascular region of the meniscus.
Recently, much interest has been paid to tissue adhesives as an alternative to sutures. Tissue adhesives are already used in clinical practice for other purposes, such as Dermabond® (2-octyl cyanoacrylate) as topical skin adhesive, fibrin glue for pulmonary leaks, and recently TissuGlu® (an FDA approved urethane-based adhesive) for abdominoplasty surgery [19, 20]. However, up to now, there is no clinically available glue suitable for the treatment of meniscal tears.
The purpose of this paper was to summarize current advances in the development of tissue adhesives, compare them with the current clinical gold standard treatments and critically evaluate their potential application in the treatment of meniscal tears. Mechanical and biological properties of the meniscus are discussed and requirements for a suitable material are formulated. Subsequently, characteristics of the main groups of tissue adhesives found in literature are discussed and conclusions and recommendations for future clinical directions are made.
2 Biology of the meniscus
3 Biomechanics of the meniscus
4 Meniscal tears and their healing potential
5 Current clinical treatment methods of meniscal tears
There are numerous techniques used in clinical practice to restore the integrity and function of torn menisci, most used are sutures, staples, stingers and screws . These devices are employed to keep the torn meniscus together enabling tissue healing. Among these techniques, suturing is superior, since it provides optimal mechanical stability and has the highest strength at failure [8, 11, 47, 48]. Different suturing techniques are used: all-inside, outside-in, inside-out, in order to provide the most suitable treatment for particular tears . The use of vertical sutures provides the best results and is therefore the current gold standard . An alternative to sutures, which are usually difficult to apply during minimally invasive surgery as the procedure is time-consuming and may induce scarring and cause problems with healing, might be using Meniscus Arrows® or Smart Nails®, which are easier to apply . However, they carry the risk of chondral abrasion, due to the fact that a part of these devices remain exposed at the surface of the meniscus and harm articular cartilage . In addition, these implants might fail, and as they are usually prepared from non-degradable materials, articular cartilage might be damaged due to the long-term presence of material debris in the knee joint.
In clinical practice, procedures aimed at increasing the rate of healing in the avascular zone are also proposed. Rasping the tissue to expose collagen fibers and induce vascularization, trephination and creation of access channels to facilitate new tissue ingrowth have been employed [53, 54, 55, 56, 57]. However, the success rate is found to mainly depend on the type and location of the tear.
6 Advances in research of meniscal tears repair
Recent advances in meniscus research suggest that the low cellularity, dense ECM and poor vascularity together with the inflammatory condition of the knee joint in general might also be responsible for the lack of healing potential. Reprogramming of the wound environment is one of the potential targets to increase the healing potential of the meniscus, but this requires extra steps in treating the tissue adjacent the tear . Amongst the procedures which were proposed are the delivery of therapeutics by biomaterial-based technologies and the partial digestion of the matrix in the torn region by collagenase which might enable the migration of cells to the wound margin and stimulate healing [59, 60]. On the other hand an approach in which the level of proteolytic enzymes is controlled may also improve meniscus capacity to repair, as the present inflammation is associated with increased synovial inflammation and increased level of the proteolytic enzymes, especially metalloproteinases (MMP) [61, 62]. In an in vitro repair and animal models it has been shown that by introducing inflammatory cytokines, such as interleukin-1, the integration of the meniscus can be reduced, while inhibiting MMPs and catabolic cytokines can restore its integration capability [63, 64, 65]. Another approach which was already proven to have a beneficial influence on meniscal repair is the injection of progenitor cells into the joint, a procedure which enhances tissue regeneration. Also growth factors, especially TGF-β, have been shown to increase proteoglycans synthesis by fibrochondrocytes from different zones of the meniscus in an in vitro cultures [66, 67, 68]. Further development of these techniques to clinical use could improve the healing capacity of the meniscus, potentially making the whole healing process shorter and more efficient.
In the light of the complexity of the biological modifications developed to improve the meniscus repair capacity, there might also be a great potential in the use of tissue adhesives. They could serve as an alternative or support for sutures, and would keep the wound edges of the tear close to each other. The use of slowly resorbable tissue adhesives would have numerous advantages, such as easy and fast application, no need of removal after the tissue is healed, and at the same time they could act as a carrier to deliver cells, growth factors, enzymes and other biological factors to the meniscus. Thus, they could be used in combination with the treatment modalities described in the previous section. There already have been attempts in the clinic to use fibrin gels in meniscus repair treatments, either as a glue or as a support to suturing [49, 50, 69, 70, 71, 72]. More details of these procedures are given later. However, until now they have not been adopted in clinical practice. It remains a challenge to develop a tissue adhesive which has all the required properties for adequate meniscal tear repair. In this review we focus on a discussion on the desired properties of glues for meniscal tear repair and how current developments in the field comply with them.
7 Requirements of tissue adhesives for use in meniscal repair
Tissue adhesives are defined as materials capable to attach and remain on surfaces of biological substrates with ability to interact with biological factors . Any tissue adhesive, regardless its intended application, should fulfil a large number of requirements to be suitable for biomedical use . Most importantly, good attachment to (wet) tissue surfaces is a prerequisite. The material must be non-cytotoxic and not induce any adverse tissue reaction. An adhesive should initially be in a liquid state with an adequate viscosity to be able to apply it only locally on the tissue in adequate amounts. There should be no need for elaborate application techniques or devices, and the adhesive should preferably be injectable. It should wet and spread over the entire surface of the tissue to be glued, resulting in effective and close contact between adhesive molecules and the surface of the tissue. Thereafter, it should solidify shortly after its application . The adhesive should achieve a stable union between the tissue surfaces until proper healing has occurred. To allow this, it must withstand forces present on the site of application. Finally, it should degrade and potentially be resorbed by the body so that the two edges of the wound can reunite to accomplish complete wound healing. Biodegradation products of the cured tissue adhesives must be not cytotoxic and must have sizes allowing their clearance by the kidney (maximally 50 kDa ). Moreover, the tissue adhesive should be shelf-stable and preferably coloured for easy visualization . Abovementioned requirements are critical for every tissue adhesive material, regardless of the site of application. For materials intended for specific purposes, additional criteria should be formulated .
To formulate specific design criteria for tissue adhesives for meniscus tear repair, the particularity of the tissue in terms of its structure, vascularisation, healing potential and its performance in loaded conditions must be considered. The adhesive has to spread well on the wet surfaces of the meniscus in a synovial environment. Subsequently, it should cure forming a solid network strong enough to withstand the forces present in the knee joint. Therefore, it should be sufficiently hydrophilic to facilitate spreading on the tissue. Secondly, in order to obtain a strong network after curing, the adhesive should preferably contain hydrophobic components as well. These components will contribute to good mechanical properties of the network after curing. The tensile modulus of the cured network should be in the same range as that of meniscus tissue in the circumferential direction, as the majority of injuries fitting criteria for repair occur in the circumferential direction . This means that it should be in the range of values between 40 and 150 MPa (see Fig. 3). The ultimate tensile strength (UTS) of the adhesive should be either higher or comparable to that of meniscus tissue, which is approximately between 12 and 19 MPa in circumferential direction (see Fig. 3).
When designing the degradation profile of the adhesive, the healing rate of the meniscus must be taken into account. In general, patients are advised to use crutches for 8–10 weeks post-surgery after repair of a meniscal tear using sutures to avoid overloading the meniscus tissue during its healing process . At the same time it has been reported that visual evidence of healing of a meniscus requires a 4 month time interval . Therefore, it would be beneficial if the tissue adhesive remains functional at the site of application for at least 4 months before it starts to degrade without rapid loss of its mechanical properties. Finally, the adhesive strength of the adhesive material should be sufficient to keep the torn meniscus together during this period of healing. However, it is hard to determine what exactly should be the adhesive strength due to variability of lesions, intended technique to be used and specificity of each patient’s case. If referred to the mechanical strength of the currently used devices for meniscus repair (sutures, stingers, screws), those depend not only on the device itself but also on the fixation method.
Rimmer et al. compared the failure strengths of 3 arthroscopic meniscal suturing methods . Depending on the technique used (a single horizontal loop, a double vertical loop, and a single vertical loop), the failure strength was between 29.3 and 67.3 N. Barber et al. compared the performance of sutures with other surgical devices . The load to failure was measured of e.g. double vertical stitch (113 N), single vertical stitch (80 N), BioStinger (57 N), a horizontal mattress stitch (56 N), a meniscus arrow (33 N) and the Biomet staple (27 N). It is evident that the variation in mechanical failure strength is broad, and the use of a particular method strongly depends on the individual case, type of lesion and the number of sutures used. Moreover, it is impossible to directly relate tensile strength of sutures with the required adhesive strength of the tissue glue. In studies analysing forces on sutured menisci (both lateral and medial) in human cadaver knee models, it was reported that the distraction forces did not exceed 5 N on average when the applied load was 300 N [81, 82]. In another study, where the distraction forces were assessed indirectly on bucket-handle lesion, the occurring forces were determined to be less than 10 N . These forces would correlate to a stress of 50–100 kPa for a tear measuring 1 cm2, and in the non-weight bearing recovery period these forces would probably be even lower. Therefore, tissue adhesives should be designed to resist physiological stresses and by that stabilize the meniscus and prevent gap formation . An adhesive material able to hold a torn meniscus together under a stress of 50–100 kPa should therefore be already sufficient for this application.
Another important aspect that should be taken into consideration in the design of a tissue adhesive for meniscus repair is the incorporation of cells or growth factors. These could enhance healing of the meniscus, especially in the inner a-vascular and a-cellular zone. The tissue adhesive can serve as a carrier for the molecules, which can be released on the site of application e.g. via diffusion process or, if the factors are bound to the glue, they could be released during degradation of the adhesive. The beneficial influence of incorporating both cells  and other biological compounds, such as bone marrow or platelet rich plasma (PRP) [84, 86], on meniscus healing have been already reported in literature.
Summary of the key requirements of tissue adhesives for meniscus repair
Cured adhesive network
- Application via syringe/needle (adequate viscosity)
- Can be applied via minimally invasive arthroscopical procedures
- Easy spreading on the tissue surface (sufficiently hydrophilic), but does not leak to surrounding tissues
-Starts to gradually degrade after 4 months of application
-Degrades to non-toxic, low molecular weight products (max 30-50 kDa), which can be renally excreted
-Cures within few minutes after application allowing surgeon to precisely place it in the tear
-Does not induce chronic inflammation
-Non-toxic degradation products
Adhesive shear strength
At least 50 kPa
-Not cytotoxic, does not induce acute inflammatory response
8 Current developments in the field of tissue adhesives
Recently, there has been much interest in the research field of tissue adhesives. Besides a few products which are already approved for clinical use (e.g. Dermabond®, Fibrin glue, TissuGlu®), most research is directed towards the development of new adhesive biomaterials and improvement of the properties of existing ones.
In general, the biomaterials used for the synthesis of glues might be composed of natural, synthetic or combination of both types of polymeric materials . Synthetic biomaterials are usually cheap and their ground substances are widely available, the mechanical and physico-chemical properties might be easy to control, but they can be toxic and may have a sub- optimal biocompatibility. Natural materials, on the other hand, offer better biological properties such as biocompatibility and good cell adhesion, but the production is more difficult to standardize due to variability of the ground substances, they are expensive and carry a risk of disease transmission . In terms of mechanisms of curing and adhesion to the tissue, the materials can be divided into several subcategories. Since numerous reviews were published recently on the chemistry and mechanisms of tissue adhesion [89, 90, 91], here only a brief description of the basic mechanisms and examples from literature are outlined.
8.1 Natural protein-based tissue adhesives
8.1.1 Fibrin adhesives
8.1.2 Gelatine adhesives
Gel-forming mechanisms similar to blood coagulation have been further investigated. Liu et al.  proposed that gelatine (as a structural protein) and calcium independent transglutaminase (mTG) (as a cross-linking enzyme) can be used (Fig. 5b). They reported that gelatine-mTG adhesives gelate in situ within few minutes (<5), adhere to tissue in the presence of blood via covelent bonds (Fig. 5c) and provide sufficient strength to be used as a surgical sealant. Also Chen et al. investigated the use of gelatine-mTG adhesives . The materials did not induce structural damage of the retina after injection into the vitreous cavity in rats and their adhesive strength to bovine retinal tissue in vitro was between 15 and 45 kPa. Moreover, peptide-conjugated polymer hydrogels formed by tissue transglutaminase cross-linking were evaluated as an adhesive on guinea pig skin and collagen membrane . The results show that the adhesive strength to the tissue was comparable to that of fibrin glue.
Other adhesives of this class are gelatine–resorcinol–formaldehyde (GRF) and gelatine–resorcinol–formaldehyde–glutaraldehyde (GRFG) glues. The gelatine is cross-linked by aldehyde via reaction with its amine groups. At the same time, aldehyde groups form covalent bonds with amines from the tissue. These materials have been utilized in aortic dissections, liver surgeries, gastrointestinal and urinary track operations . However, safety issues have arisen regarding their toxic degradation product—formaldehyde.
8.1.3 Albumin adhesives
Although natural protein-based cross-linked adhesives have excellent biocompatibility, their bonding strength to the tissue is relatively low, usually in the range of 10–40 kPa. After curing they form networks with the relatively low mechanical properties of soft hydrogels, which limit their application in load bearing sites in the body. Moreover, they are rapidly degraded by enzymes from the body. Normally they degrade within 2 weeks , which is too fast for meniscus repair. These glues are however applicable for pulmonary leaks, for haemostasis in vascular surgery and for treatment of cerebrospinal leaks.
8.2 Nature-inspired (biomimetic) tissue adhesives
Another similar mechanism is present in red and brown algae, which also, like mussels, excrete phenolic compounds that can bind to both hydrophobic and hydrophilic surfaces in aqueous conditions. The produced polyphenols are activated by a vanadate-peroxidase type of enzyme that allows the cross-linking of the polyphenol with the extracellular carbohydrate fibers, which will finally lead to adhesion to a surface . Natural algal-borne polyphenol can be successfully replaced by phloroglucinol. Formulations composed of phloroglucinol, alginate and calcium ions are capable of adhering to a variety of surfaces including porcine tissue .
One of the strategies to induce a better and stronger interaction with a surface is the increase of the contact area. Geckos have used this in an interesting adhesive strategy that relies on foot pads composed of keratinous foot-hairs that are split into terminal spatula of a size of 200 nm . The adhesion mechanism is based on capillary forces and van der Waals interactions. Inspired by this natural phenomena, Geim et al. developed an adhesive composed of dense arrays of flexible pillars to ensure their collective adhesion. However, problems related to their durability were encountered . To resolve these problems Lee et al. developed an adhesive inspired by mussels and geckos, which combine excellent properties of both mechanisms, and can bind to the surfaces both in dry and wet environment in multiple cycles. The adhesive force in a wet environment was calculated to be equivalent to 90 kPa . Szomor and Murrel tested a naturally-sourced glue secreted by Australian frogs (genus Notaden) on sheep meniscus tissue and reported that the adhesive strength of this glue (~90 N) is superior both to fibrin glue (5 times stronger) and gelatine (2.5 times stronger) .
Based on recent literature, it can be concluded that biomimetic tissue adhesives have the potential to be used in numerous applications. In general, the adhesive strength of this class of materials is reported to be 20–90 kPa [103, 108, 110]. The cytocompatibility is dependent on the amount of material added to cells, but in vivo tests showed no adverse tissue reactions . However, there is almost no information about degradation profiles of the reported adhesives and of the mechanical properties of the cured networks. Therefore, it cannot be indisputably concluded that these materials could be suitable for treating meniscal tears.
8.3 Synthetic and hybrid tissue adhesives
Another group of adhesives are polymers, natural, synthetic or combination of both, whose end-groups have been modified in a way that allows simultaneous curing and attachment to the tissue. Examples of this class are cyanoacrylates, materials containing N-hydroxysuccinimide (NHS)- or isocyanate-terminated polymers, as well as polymers that can be photo cross-linked or those forming networks due to physical interactions e.g. due to thermal gelation.
8.3.1 Cyanoacrylate adhesives
Commercially available Dermabond® and Histoacryl® are widely used as topical skin adhesives, but they are not bio-absorbable and therefore in clinical practice they are used only for skin wounds . Still, the use of Histoacryl® has been compared with sutures in delaying the formation of a 2 mm meniscal gap . The bovine menisci were placed in a tensile loading machine and the force needed for gap formation was measured. The tear was repaired with either vertical sutures, Histoacryl® or both. It was found that Histoacryl® gluing is superior to vertical sutures regarding gap delaying. However, the best results were obtained when glue and sutures were used together. Reckers et al. reported an in vivo study of cyanoacrylate surgical adhesives used for the fixation of transplanted menisci in rabbits . It was concluded that the glue induced necrosis from the cortex to the bone marrow of transplanted bone surface. In order to improve the biocompatibility and mechanical properties of cyanoacrylates, Lim et al. mixed cyanoacrylate with poly-l-DOPA  in order to improve the physiochemical properties of cyanoacrylate for use as tissue glue. Lim and Kim also proposed to mix the cyanoacrylate component with poly(l-lactide-co-caprolactone) to obtain a biodegradable elastomer . They reported that, although the adhesive strength was decreased compared to a pure cyanoacrylate compound, the biocompatibility and flexibility were improved. This indicates that these materials are more suitable for specific biomedical applications.
In conclusion, of all known adhesives, cyanoacrylates are the class of adhesives that form the strongest bond with tissue. Their adhesive strength values, depending on the tissue type and type of test performed, are reported to be in the range of up to a few MPa (30 kPa adhesive strength to skin up to 2 MPa to bone) [86, 122, 123]. So far, their toxicity limits their application within the body and they have been FDA-approved only for topical skin wound closure. Moreover, their high stiffness (high E modulus), limits their application in soft tissues, such as meniscus.
8.3.2 Chemically cross-linkable adhesives
Taguchi et al.  investigated biodegradable adhesives composed of human serum albumin (HSA) and organic acid-based cross-linkers (trisuccinimidyl citrate, disuccinimidyl tartarate (DST) and disuccinimidyl malate) with activated NHS groups. The best results were obtained using DST. The adhesive strength of these biocompatible and bioresorbable materials was better than that of fibrin glue. The active ester groups present in DST react with the amine groups from HAS and collagen molecules from the tissue. The adhesive composed of DST/HSA was evaluated in the gluing of meniscal tears . Glued and sutured porcine menisci were implanted subcutaneously in rabbits, and after 3 months, tensile tests and histology were done. Comparisons were made between tears treated with sutures, tears treated with sutures soaked with adhesive and tears treated with only adhesive. The results showed best performance when the sutures were soaked with adhesive (~70 N), followed by sutures (~61 N) and adhesive (~60 N) only. This indicates the potential of this class of materials in meniscal repair.
Adhesives comprising isocyanate-terminated molecules have a similar bonding mechanism. They form a covalent bond with the tissue and cure to form polyurethane networks upon contact with the surrounding fluids , see Fig. 9b. Compared with other biomaterials, polyurethanes possess many advantages, such as high tenacity, toughness, water and chemical resistance and mechanical flexibility . Biodegradable polyurethanes are designed to undergo (enzymatic) hydrolytic degradation to non-cytotoxic products . Mostly aliphatic diisocyanates are used in the design of biomaterials intended for biomedical use, since it has been shown that they exhibit lower toxicity comparing to aromatic ones .
Hadba et al. described the development of two compositions of branched isocyanate-functional adhesives based on poly(ethylene glycol) and adipic acid functionalized with 2,4-toluene diisocyanate (TDI) or 4,40-methylene-bis(phenyl isocyanate) (MDI) . The adhesive strength of the formulated materials to porcine stomach tissue depended on the specific formulation, the highest value determined was approximately 100 kPa (1093 gf/cm2).
Rohm et al. and Sternberg et al. [116, 132] reported the use of mixtures of 1,2-ethylene glycol bis-(dilactic acid) functionalized with hexamethylene diisocyanate (HDI) with different biodegradable polymers such as hyaluronic acid, gelatin, chitosan acetate and chitosan chloride. The obtained products had promising properties in terms of biodegradability, biocompatibility and adhesive strength (which was similar or better than fibrin glue). The solidification speed could be adjusted by using aqueous solution of chitosan chloride as a second component of the adhesive system.
Nayeb-Habib et al. developed a isocyanate pre-polymer and chitosan gel based tissue adhesive in order to combine good adhesion of isocyanates and biocompatibility and healing properties of chitosan . Degradation products of this polymer did not induce any toxicity. Field et al. evaluated two isocyanate-based adhesives to repair full thickness meniscal wounds in an ovine model in vivo over a period of 1 month . A 10 mm defect in the medial meniscus was repaired with these adhesives, and after 1 month signs of repair and tissue regeneration were observed and no adverse inflammatory reaction was present. Nevertheless, despite the progress in the development of less toxic materials with suitable mechanical properties and satisfactory curing times, until today there is only one isocyanate-based tissue adhesive commercially available: TissuGlu® (Cohera Medicals Inc®). It is FDA-approved for use in abdominoplasty surgery.
8.3.3 Photo cross-linkable adhesives
Another interesting class of tissue adhesives are those that are photo cross-linkable, an example is commercially available FocalSeal. It is a copolymer composed of hydropihilic polyethylene glycol (PEG), and glycolide or lactide, trimethylene carbonate and acrylic acid moieties. These materials are crosslinked by light, which also initiates their adhesion to tissue . The acrylate groups covalently bind to the amine groups of the tissue and form an interpenetrating network upon curing. The material is biodegradable; resorption takes approximately 3 months . The application process, however, is complicated because delivery of a source of curing light to the application site can be technically difficult.
In another study Lang et al. developed acrylate-functionalized copolymers based on sebacic acid and glycerol that could be cross-linked with light . The materials were used in vivo to attach a polymeric patch to the beating heart of rats and pigs. The patch remained in place even under higher than normal heart beat rates.
Ishihara et al.  worked on chitosan derivatives that could be crosslinked with UV light. The chitosan hydrogel obtained could stop bleeding from a cut mouse tail and keep two pieces of sliced mouse skin together. Moreover, application of the chitosan hydrogel induced significant wound contraction and accelerated wound closure and healing.
8.3.4 Thermo-responsive adhesives
A different group of materials are those, which can be cross-linked physically. Lando et al. and Cohn et al. developed an interesting approach, in which thermo-responsive biodegradable copolymers based on lactide-ε-caprolactone and three-armed trimethylolpropane-lactide-ε-caprolactone were used as tissue adhesives [139, 140]. These low molecular weight materials were in a flow state with low viscosity at the temperature of application and could attain high viscosity at the body temperature. The adhesive failure strength to polyamide (6,6-nylon) films, which was used as a model for a tissue, was measured to be up to 2 N/cm width of the film.
Although chemically modified tissue adhesives hold great potential for use in a variety of medical applications, further studies are required to develop materials for specific applications such as the treatment of meniscus tears.
8.4 Formulation of tissue adhesives with biological factors
It has been recognized that incorporation of biological molecules, growth factors, platelet rich plasma (PRP), bone marrow (BM) and living cells to the adhesive can enhance healing of the tissue . Ishimura et al. reported an experimental study in which they incorporated marrow cells into fibrin gel and compared the healing rate of the torn meniscus with fibrin gel that did not contain cells . The results showed faster and more mature healing of defects in the group, which contained marrow cells. A similar approach was used by Scotti et al.: To improve the bonding between two swine meniscal slices, articular chondrocytes were added to a fibrin glue gel. The bonding capacity was evaluated in a nude mouse model after implantation for 4 weeks . The results showed firm gross bonding in the experimental samples, while no bonding was observed in the control samples that did not contain cells. Although the success of this approach has only been described in a limited number of studies, the very promising results obtained justify the further investigation of cell-containing adhesives for meniscus repair.
9 How do tissue adhesives compare with the requirements for repair of the damaged meniscus and the current gold standard treatment?
The most important prerequisites for a tissue adhesive to be suitable for meniscus tear repair include: adequate mechanical properties; suitable degradation profile, sufficient adhesive strength, short curing times and good biocompatibility (see Table 1). Comparing these requirements with the properties of the tissue adhesives described above, it can be concluded that up to now no tissue adhesive material has yet been developed that fully complies with all requirements. However, this not only due to sub-optimal properties of the adhesives, such as insufficient bonding strength in the case of enzymatically cross-linked adhesives or poor biocompatibility in the case of cyanoacrylates. It is also due to lack of the data that is required to be able to conclude if a certain material is suitable for the intended application. Simson et al., for example, described a promising bone marrow-chondroitin sulphate tissue adhesive for meniscus repair, however no information regarding its biodegradability was presented.
Moreover, although lap shear adhesion tests are one of the most often employed methods to assess the adhesive strength of newly developed glues, the conditions under which these tests are conducted are not standardized. There have been many substrates and tissue models used to evaluate the adhesion strength of tissue adhesives, e.g. polyamide films [139, 140], gelatin pieces [142, 143, 144], collagen membranes , and even pig skin and wood . Additionally, very different environments (wet or dry), gluing temperature and the curing times have been used. These large variations make direct comparison of the outcomes of described experiments difficult.
Up to now, there have been only few clinical studies reporting the use of tissue adhesives in the repair of meniscal tears, all studies involved fibrin glue. As this particular adhesive has poor mechanical- and adhesive properties, it cannot be used as to replace the use of sutures as gold standard. There is much interest in the development of new adhesive materials. However, more systematic (clinical) research is needed before the suitability of a newly developed tissue adhesive for the intended application can be proven.
Among the methods currently used to repair meniscus, the ideal solution has not yet been found. Tissue adhesives hold great potential to replace or support sutures and staples. Many new adhesive materials with a good prognosis for use in a variety of applications have been developed. However, most of them have not been sufficiently characterized to be able to qualify them as being suitable for meniscus repair. Nevertheless, chemically cross-linked adhesives seem the most versatile as these are based on existing natural or synthetic polymers and can be readily modified. Their properties can be adjusted by careful molecular design and chemical functionalization to make them suitable for the intended application.
Standardized relevant biomechanical and biological models need to be defined to compare different available and developed tissue adhesives, and to be able to address their suitability for the repair of meniscal tears. In clinical practice, the most successful treatment modality remains the use of sutures. Nevertheless, there is great need for a suitable meniscus tissue adhesive. Such adhesive should be easily applied in a meniscal tear, bind strongly to meniscal tissue, hold the torn region together, facilitate its healing, and then gradually degrade into non-toxic products.
- 1.Burr DB, Radin EL. Meniscal function and the importance of meniscal regeneration in preventing late medical compartment osteoarthrosis. Clin Orthop Relat Res. 1982;171:121–6.Google Scholar
- 2.Cooper DE, Arnoczky SP, Warren RF. Meniscal repair. Clin Sports Med. 1991;10(3):529–48.Google Scholar
- 6.Krause WR, Pope MH, Johnson RJ, Wilder DG. Mechanical changes in knee after meniscectomy. J Bone Joint Surg Am. 1976;58(5):599–604.Google Scholar
- 16.van Trommel MF, Simonian PT, Potter HG, Wickiewicz TL. Different regional healing rates with the outside-in technique for meniscal repair. Am J Sports Med. 1998;26(3):446–52.Google Scholar
- 19.Gilbert TW, Badylak SF, Beckman EJ, Clower DM, Rubin JP. Prevention of seroma formation with TissuGlu® surgical adhesive in a canine abdominoplasty model: long term clinical and histologic studies. J Plast Reconstr Aesthet Surg. 2013;66(3):414–22. doi: 10.1016/j.bjps.2012.09.029.CrossRefGoogle Scholar
- 25.Bennet, G.A.W., Waine, H., Bauer, W.: Changes in the knee joint at various ages: with particular reference to the nature and development of degenerative joint disease. New York: The Commonweath Fund; 1942.Google Scholar
- 26.McNulty AL, Guilak F. Integrative repair of the meniscus: lessons from in vitro studies. Biorheology. 2008;45(3):487–500.Google Scholar
- 27.McDevitt CA, Webber RJ. The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop Relat Res. 1990;252:8–18.Google Scholar
- 29.Brindle T, Nyland J, Johnson DL. The meniscus: review of basic principles with application to surgery and rehabilitation. J Athl Train. 2001;36(2):160–9.Google Scholar
- 32.Shrive NG, O’Connor JJ, Goodfellow JW. Load-bearing in the knee joint. Clin Orthop Relat Res. 1978;131:279–87.Google Scholar
- 35.Fithian DC, Kelly MA, Mow VC. Material properties and structure-function relationships in the menisci. Clin Orthop Relat Res. 1990;252:19–31.Google Scholar
- 47.Henning CE, Lynch MA, Yearout KM, Vequist SW, Stallbaumer RJ, Decker KA. Arthroscopic meniscal repair using an exogenous fibrin clot. Clin Orthop Relat Res. 1990;252:64–72.Google Scholar
- 73.Sheikh N, Mirzadeh H, Katbab AA, Salehian P, Daliri M, Amanpour S. Isocyanate-terminated urethane prepolymer as bioadhesive material: evaluation of bioadhesion and biocompatibility, in vitro and in vivo assays. J Biomater Sci. 2001;12(7):707–19. doi: 10.1163/156856201750411611.CrossRefGoogle Scholar
- 75.Chu C-C, Anthony von Fraunhofer J. Wound closure biomaterials and devices. 1st ed. Boca Raton: CRC-Press; 1997.Google Scholar
- 78.DeHaven KE. Meniscus repair. Am J Sports Med. 1999;27(2):242–50.Google Scholar
- 98.Kucukaksu DS, Akgul A, Cagil K, Tasdemir O. Beneficial effect of BioGlue (R) surgical adhesive in repair of latrogenic aortic dissection. Tex Heart Inst J. 2000;27(3):307–8.Google Scholar
- 100.Lee Y, Chung HJ, Yeo S, Ahn CH, Lee H, Messersmith PB, et al. Thermo-sensitive, injectable, and tissue adhesive sol-gel transition hyaluronic acid/pluronic composite hydrogels prepared from bio-inspired catechol-thiol reaction. Soft Matter. 2010;6(5):977–83. doi: 10.1039/b919944f.CrossRefGoogle Scholar
- 122.Weber SC, Chapman MW. Adhesives in orthopaedic surgery a review of the literature and in vitro bonding strengths of bone-bonding agents. Clin Orthop Relat Res. 1984;191:249–61.Google Scholar
- 126.Inoue, T., Taguchi, T., Imade, S., Kumahashi, N., Uchio, Y.: Effectiveness and biocompatibility of a novel biological adhesive application for repair of meniscal tear on the avascular zone. Sci Technol Adv Mater. 2012;13(6).Google Scholar
- 133.Nayeb-Habib F, Salahshoor-Kordestani S, Afshar-Taromi F, Shariatinia Z. A novel topical biocompatible tissue adhesive based on chitosan-modified urethane pre-polymer. Iran Polym J. 2011;20(8):671–80.Google Scholar
- 145.Scotti C, Hirschmann MT, Antinolfi P, Martin I, Peretti GM. Meniscus repair and regeneration: review on current methods and research potential. Eur Cells Mater. 2013;26:150–70.Google Scholar
- 146.Matsuda M, Ueno M, Endo Y, Inoue M, Sasaki M, Taguchi T. Enhanced tissue penetration-induced high bonding strength of a novel tissue adhesive composed of cholesteryl group-modified gelatin and disuccinimidyl tartarate. Colloids Surf B. 2012;91:48–56. doi: 10.1016/j.colsurfb.2011.10.030.CrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.